Lineage Cell Therapeutics
LCTX
$1.15
Share price
-4.17%
Change (1 day)
-17.27%
Change (1 year)
Categories
Market capitalization of Lineage Cell Therapeutics (LCTX)
Market cap: $0.21 Billion
As of April 2024 Lineage Cell Therapeutics has a market cap of $0.21 Billion. This makes Lineage Cell Therapeutics the world's 6840th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Lineage Cell Therapeutics from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.21 B | 13.67% |
| 2023 | $0.19 B | -4.09% |
| 2022 | $0.19 B | -51.84% |
| 2021 | $0.41 B | 56.44% |
| 2020 | $0.26 B | 98% |
| 2019 | $0.13 B | 14.86% |
| 2018 | $0.11 B | -57.44% |
| 2017 | $0.27 B | -26.48% |
| 2016 | $0.37 B | 0.08% |
| 2015 | $0.37 B | 27.05% |
| 2014 | $0.29 B | 42.91% |
| 2013 | $0.20 B | 31.67% |
| 2012 | $0.15 B | -46.89% |
| 2011 | $0.29 B | -21.73% |
| 2010 | $0.37 B | 161.91% |
| 2009 | $0.14 B | 238.15% |
| 2008 | $42.11 M | 345.76% |
| 2007 | $9.44 M | 57.94% |
| 2006 | $5.98 M | -13.62% |
| 2005 | $6.92 M | -74.25% |
| 2004 | $26.89 M | 42.73% |
| 2003 | $18.84 M | -13.77% |
| 2002 | $21.85 M | -59.14% |
| 2001 | $53.48 M |
End of Day market cap according to different sources
On Apr 18th, 2024 the market cap of Lineage Cell Therapeutics was reported to be:
$0.22 Billion
$0.22 Billion
$0.22 Billion
$0.22 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.61 B | 185.58% | 🇺🇸 USA |